Objectives: Fibromyalgia (FM) characteristics can be evaluated using a simple, self-reported measure that correlates with postoperative opioid consumption after lower-extremity joint arthroplasty. The purpose of this study was to determine whether preoperative pain history and the FM survey score can predict postoperative outcomes after shoulder arthroscopy, which may cause moderate to severe pain.
S
houlder arthroscopy is a minimally invasive procedure that can cause moderate to severe postoperative pain. 1 However, it is unclear if preoperative characteristics could be used to identify shoulder arthroscopy patients at risk for poorer postoperative outcomes. Measures that may influence postoperative outcomes include psychological factors, 2 degree of pain 3 and physical functioning, 4 overall pain sensitivity, 5 and preoperative opioid use. 6 Fibromyalgia (FM), which is characterized by the centrally mediated augmentation of pain and sensory processes, may also influence postoperative outcomes. 7 Although the cause of FM cannot be detected through examinations, 8 its mechanistic underpinnings have been demonstrated. 9 In 2011, a self-report questionnaire that assesses widespread body pain and comorbid symptoms of FM was created. This questionnaire evaluates the fibromyalgia survey score (FMSS) as "a continuum of sensitivity and symptomatology," which may correlate with adverse pain outcomes, 10 and may be used epidemiologically to detect "fibromyalgia-like" characteristics outside of pure cohorts. 9 A recent study showed that lowerextremity joint arthroplasty patients with higher FMSS were younger, had greater preoperative pain, consumed more opioids preoperatively, had negative psychological profiles, and consumed more opioids postoperatively even when accounting for other preoperative measures. 11 In another study, the FMSS was predictive of postoperative opioid consumption in patients undergoing hysterectomy. 12 Whether preoperative pain history or the FMSS can predict pain outcomes after ambulatory shoulder arthroscopy, which causes a wide range of postoperative pain, is unknown. The FMSS has not been characterized in this patient population. In this prospective, observational cohort study, multiple validated self-report questionnaires were used to assess FMSS and other measures in shoulder arthroscopy patients. Given the known central nervous system abnormalities in FM, including higher endogenous opioid levels and lower mopioid receptor availability, 13, 14 we hypothesized that higher preoperative FMSS would independently predict poorer postoperative outcomes. The primary outcome was opioid consumption on postoperative day (POD) 2.
MATERIALS AND METHODS

Patient Identification and Recruitment
for Special Surgery (#2013-002), and written informed consent was obtained from all patients in the holding area before surgery. The reporting of this study conforms to the STROBE Statement. 15 Patients (18 to 80 y old) undergoing shoulder arthroscopy between August 2013 and January 2014 were assessed for eligibility. Exclusion criteria included allergies to study medications (eg, nonsteroidal anti-inflammatory drugs and opioids), contraindications to supraclavicular nerve blocks, non-English speakers, chronic opioid use, and open procedures. Chronic opioid use was defined by daily use of any opioid for 5 of the 7 days before surgery.
Surgical and Anesthetic Procedures
Patients undergoing any type of shoulder arthroscopy, including rotator cuff repairs, subacromial decompressions, labral repairs, stabilizations, debridements, and biceps tenodesis, were enrolled. All patients were scheduled to receive a supraclavicular nerve block containing 30 to 45 mL of a combination of 1.5% mepivacaine and 0.5% bupivacaine. Patients also received either intravenous sedation (up to 5 mg midazolam; propofol infusion, up to 100 mcg fentanyl) or general anesthesia (midazolam, propofol infusion, nitrous oxide, isoflurane, up to 100 mcg fentanyl) at the discretion of the anesthesiologist after determining patient and surgeon preferences. Intravenous famotidine (20 mg), ondansetron (4 mg), dexamethasone (4 mg), and ketorolac (30 mg) were administered. In the postanesthesia care unit, patients were not prophylactically given opioid medication unless they requested medication or had numerical rating scale pain scores >3. Patients were prescribed opioids (oxycodone/acetaminophen or hydrocodone/acetaminophen) and nonsteroidal anti-inflammatory drugs (naproxen) for postoperative use.
Surgery types were divided into "more-painful" and "less-painful" groups. Rotator cuff repairs, labral repairs, stabilizations, and biceps tenodesis were classified as "more painful." 16 Decompressions and debridements were classified as "less painful." 16 
Preoperative Phenotyping
The following self-report measures were assessed preoperatively using validated instruments, as previously described 11 : (1) Pain severity at the surgical site (average of worst, least, and average pain scores; taken from Brief Pain Inventory), 17 (2) Widespread pain (Michigan Body Map), 11, 18 (3) Neuropathic pain at the surgical site (PainDETECT), 19 (4) Physical functioning (PROMISPhysical Function-Short Form 1, 2008; http://www.nihpromis.org), (5) Quality of Recovery-9, 20 (6) Depressive and anxiety symptoms (Hospital Anxiety and Depression Scale), 11, 21 (7) Catastrophizing (Coping Strategies Questionnaire), 22 and (8) Symptom severity scale. 11 Using the 2011 Survey Criteria for Fibromyalgia described previously, 10,11 the widespread pain index (0 to 19) and symptom severity scale (0 to 12) were added to generate the FMSS (0 to 31). Patients were divided into tertiles based on the distribution of FMSS within the cohort.
Demographic information was collected from electronic medical records. Intraoperative data, including type of arthroscopy, anesthetic type, block induction end time, and nerve block components, were obtained from anesthesia and peripheral nerve block records.
Assessment of Acute Pain
POD 2 follow-ups were performed by telephone surveys, and POD 14 follow-ups were performed by telephone or online surveys, depending on each patient's preference. On POD 2, patients answered questions regarding opioid consumption, pain scores (at rest, with movement, worst pain, least pain, and average pain), neuropathic pain (PainDETECT), physical functioning (PROMIS), and quality of recovery (Quality of Recovery-9). Patients were also asked to report the time at which their blocks completely wore off, and block duration was calculated from induction end time. On POD 14, opioid consumption and pain scores were recorded. All opioid amounts were converted to oral morphine equivalents. 23 
Statistical Analysis
Data were collected and managed using Research Electronic Data Capture (REDCap; National Center for Advancing Translational Science of the National Institute of Health, UL1TR000457) tools hosted at the Hospital for Special Surgery. 24 REDCap was also used to administer online surveys to patients who preferred online to telephone information gathering.
The primary outcome was opioid consumption on POD 2. The power analysis was calculated using the scaled dataset by Brummett et al. 11 The power for the association between opioid consumption and the FMSS was based on a test of a FM coefficient in a linear regression model, where the FM coefficient was 1.8 and the residuals SE was 20, thus giving an effect size of 0.4. To detect the association at 90% power (a = 0.5), a total N of 68 would be needed, assuming a similar distribution of FMSS in this shoulder surgery cohort. We chose a sample size of 100 to account for dropouts, exclusions, and withdrawals, as well as the possibility of a narrower range of FMSS in this patient population.
For descriptive data, univariate analyses were performed, and the means and SDs are presented. Outcome measures (opioid consumption [primary] , change in pain scores, and change in quality of recovery) were analyzed using linear-mixed models that were conducted to assess the independent contributions of the demographic and phenotypic variables. Modelbased hypotheses testing and backwards variable selection were conducted using likelihood ratio tests. 11 P < 0.05 was considered to be significant. To correct for possible overfitting and to have an unbiased assessment of the model's predictive performance, regularized variable selection was performed using adaptive LASSO and the Bayesian Information Criterion (BIC).
RESULTS
Patient Enrollment
A total of 178 patients were assessed for eligibility. Fifty-three patients were excluded (Fig. 1) . Of these, 100 (80%) patients agreed to participate. No significant differences in sex (P = 0.648), race (P = 0.772), or age (P = 0.393) were observed between study participants and patients who declined study participation. Three patients did not receive nerve blocks, as per the anesthesiologist's decision in the operating room, and were excluded from the study. Another 2 patients withdrew before POD 2: 1 developed unrelated complications, and the other was advised by her personal care provider to withdraw from the study. Three patients could not be reached for postoperative follow-ups (Fig. 1) . Data analysis was performed for the remaining 92% of patients.
Distribution of Fibromyalgia Survey Scores
FMSS ranged from 0 to 13, out of a maximum of 31 ( Fig. 2 ; mean [SD]: 5.0 [3.3] ). For univariate analyses, patients were divided into tertiles, which were referred to as "very-low" (0 to 2; n = 35), "low" (3 to 6; n = 33), and "moderate" (7 to 13; n = 24) groups (Table 1) .
Basic Demographics and Preoperative Phenotypes
There were no significant differences in age (Table 1 ). There were a higher percentage of females in the moderate group compared with the very-low group (P = 0.031). A larger percentage of whites were observed in the low group compared with the moderate group (P < 0.001).
Preoperatively, higher FMSS were associated with increased pain severity at the surgical site (P = 0.047). Neuropathic pain scores were significantly different between very-low and low or moderate groups. No differences in the duration of pain at the surgical site were observed between very-low and low groups; however, longer durations were reported in the moderate group compared with the low group (P = 0.047). Few patients took opioids before surgery, as patients with chronic opioid use (defined as daily use of any opioid for 5 of the 7 d before surgery) were excluded from the study, and preoperative opioid use was not significantly different between groups (Table 1) .
Lower results on preoperative physical functioning and quality of recovery scores were also associated with increases in FMSS, and significant differences among groups were observed (Table 1) . Depressive symptoms (0 to 21) were significantly greater in the moderate group than the low group (P = 0.003). Anxiety symptoms (0 to 21) were also significantly different between low and moderate groups (P = 0.027) and between very-low and moderate groups (P < 0.001). In addition, significant increases between groups were observed for catastrophizing (0 to 36). Furthermore, no differences in surgery type or anesthesia type were observed between the 3 tertiles of FMSS.
Univariate Postoperative Pain Outcomes
The primary outcome of opioid consumption was assessed on POD 2. No differences in opioid consumption were observed between the 3 tertiles of FMSS (Table 2 ). There were also no differences in the self-reported duration of the nerve block. No significant differences in pain severity scores were observed between groups. There were significant differences in physical function on POD 2, but the differences in quality of recovery and neuropathic pain were not significant in univariate analyses.
On POD 14, however, there was an association of increased opioid consumption with higher FMSS. At this timepoint, opioid consumption was much higher in the low group than in the very-low group. Pain severity was only significantly different between very-low and low groups (P = 0.016) ( Table 2 ).
Multivariate Postoperative Pain Outcomes
A multivariate linear-mixed model including all of the preoperative measures was used to determine characteristics independently associated with postoperative opioid consumption. Preoperative opioid use was associated with increased postoperative opioid consumption. As expected, the POD 14 timepoint was also associated with increased postoperative opioid consumption. No other associations were found (Table 3) . Regularized variable selection using adaptive LASSO did not yield a better model per BIC (2172.49 for the regularized vs. 2164.10 for the reported model). The intercept represented the mean value of postoperative opioid consumption when all characteristics were set as "0." Similar multivariate linear-mixed models were used to determine independent predictors of other postoperative outcomes. In particular, the FMSS was independently associated with poorer overall recovery, as measured by the change in quality of recovery score from baseline to POD 2. Preoperative opioid use and male sex were also independently associated with poorer recovery (Table 4) . Regularized variable selection yielded a model with inferior BIC (916.13, regularized vs. 840.67, reported model), and is not reported. Model diagnostics was performed using standardized residual plots and did not reveal any violation of model assumptions. Although the study was underpowered to robustly analyze individual item level data from the quality of recovery questionnaire, each item was assessed individually. The FMSS was independently associated with worse scores on the "Been free from headache, backache, or muscle pains" item (item level data not shown).
DISCUSSION
This is the first study to examine whether the preoperative pain history, along with the FM survey tool, could predict postoperative pain outcomes in shoulder arthroscopy patients. Higher FMSS were not independently associated with postoperative opioid consumption in this patient population. Preoperatively, higher FMSS were associated with a worse pain phenotype, including higher depressive and anxiety symptoms, catastrophizing, and neuropathic pain, as well as decreased physical functioning and quality of recovery scores. Although the primary outcome was negative, lower preoperative fibromyalgia survey scores were independently associated with increased postoperative quality of recovery scores.
Shoulder surgeries are commonly performed to treat musculoskeletal pain. 25 Although patients undergoing lower-extremity joint replacement represent a population with more severe pain and dysfunction, it is possible that similar pain phenotypes could be seen in a shoulder surgery population. As was seen in the present study, the FMSS was recently shown to be associated with a worse preoperative pain phenotype in lower-extremity joint replacement patients. 11 In the previous study, the FMSS was also independently associated with higher postoperative opioid consumption, suggesting that it can predict postoperative pain outcomes. This led to the hypothesis that the FMSS may predict postoperative pain outcomes in other cohorts. Shoulder arthroscopic surgeries can potentially result in moderate to severe pain, 1,25 although they are less invasive than lower-extremity joint replacement surgeries. On POD 2, the lowest tertile of FMSS had significantly better physical function when compared with the other groups, as well as nonsignificant trends in lower opioid consumption, pain scores, and neuropathic pain.
In multivariate modeling, the only outcome measure that correlated with the continuous FMSS was the change in the quality of recovery scale. The specific components of this scale that were independently associated with the FMSS were the incidence of headaches, backaches, or muscle pains. The quality of recovery questionnaire has been used to evaluate postsurgical and postanesthetic recovery. 26 This correlation suggests that certain preoperative aspects of patients with higher FMSS, such as headaches, backaches or muscle pains, can predict decreases in the quality of recovery after surgery.
The FM in our cohort ranged from 0 to 13 with a mean score of 5.0 (SD, 3.3), and only 2 patients had a score of 13. In this population, with FMSS that were overall low and in a Unless otherwise noted, results are represented as mean (SD). IV indicates intravenous; QoR-9, 9-item quality of recovery assessment score; SCB, supraclavicular block. *P < 0.05.
relatively narrow range, the scores were not independent predictors of postoperative pain. Furthermore, this range was substantially narrower than that reported in lowerextremity joint arthroplasty patients, in which the mean score was 6.4 (SD, 4.2), with approximately 8.5% with a score of 13 or greater. 11 Another distinguishing feature of the cohort in this study was the exclusion of patients chronically taking opioids preoperatively. The rationale was to exclude opioid-tolerant patients to better assess opioid responsiveness; however, doing so may have also excluded patients that were more "FM-like." Studies have shown that many patients with FM are prescribed opioids, 27, 28 despite expert opinion that they are not efficacious. 9 Another study from a tertiary care pain clinic found that patients taking opioids with persistently high pain despite opioid therapy appeared more FM-like. 29 In the study of lower-extremity replacement surgeries, 11 the highest fibromyalgia tertile was more likely to be taking opioids and also on higher doses. Whereas preoperative opioid use was similarly predictive of increased postoperative opioid use, the FMSS predicted additional variance. In our study, however, of the 178 patients who were assessed for eligibility, only 7 (4%) patients were excluded for chronic opioid use.
In the present study, patients in the low FM group consumed more opioids postoperatively and had higher pain scores than patients in the very-low FMSS group on POD 14. It is therefore possible that the moderate use of opioids in the low group confounded the outcomes with respect to the FMSS. Patients in the highest fibromyalgia tertile were also more likely to have had surgery that was deemed less painful, although this was not significant.
Although the FMSS did not appear to predict postoperative pain outcomes, there are several strengths of this study. It is the first to assess FMSS in shoulder arthroscopy patients, and the outcomes data were collected prospectively. It is also the first to assess the FM measure in an ambulatory setting, as the previous study by Brummett et al 11 was performed in an inpatient setting with more complicated surgeries.
Our findings further increase our knowledge of acute postsurgical pain, especially with regard to fibromyalgia and other pain-related factors, such as anxiety and quality of recovery. Despite a great deal of interest in the topic, predicting and adequately treating acute and subacute pain remains challenging. Many experts have suggested that measures of depression, anxiety, and catastrophizing can predict pain and opioid use postoperatively; however, these measures were not independently associated with the acute pain outcomes assessed in this population.
Limitations
The range of FMSS was quite narrow, as compared with the lower-extremity joint arthroplasty study. 11 FMSS in that cohort ranged from 0 to 31, whereas the maximum score in our cohort was 13. It is unclear whether the different results in this study compared with the lowerextremity joint arthroplasty study are related to different surgical procedures or patient populations with a different extent of "fibromyalgia-ness." Another possible explanation for differing results is that in this study, opiates were given for pain scores >3, whereas criteria were not specified in earlier studies. Furthermore, it is unknown if general anesthesia alone, without a peripheral nerve block, would Results are represented as mean (SD). OME indicates oral morphine equivalents; QoR-9, 9-item quality of recovery assessment score. *P < 0.05. It may be that the use of a structured regional anesthesia protocol and multimodal analgesic regimen led to a lower effect size for opioid consumption, thereby leaving the study underpowered to detect any differences. Given that this is the first study to ever investigate the associations between higher FMSS and opioid consumption in a shoulder surgery population, power was determined using data from knee and hip arthroplasty. 11 We also excluded patients who used opioids daily, whereas these patients were included in the arthroplasty study. However, of the 178 patients that were assessed for eligibility, only 7 were excluded for having chronic opioid use. Lastly, given the narrow, lower range of FMSS in this cohort, it is possible that a difference would have been seen with a larger cohort.
CONCLUSIONS
The FMSS did not predict postoperative opioid consumption and pain in shoulder arthroscopy patients at our institution. However, the measure did predict poorer quality of postoperative recovery, thus indicating a possible need for closer follow-up. Higher FMSS were also associated with a worse preoperative pain phenotype. This suggests that it can be reliably used as a simple means to categorize patients preoperatively. Further studies are needed to determine whether the FM survey measure can be used to predict postoperative pain after other types of surgical procedures in different outpatient populations. 
